Innate Pharma (OTC:IPHYF) Stock, Earnings Estimates, EPS, And Revenue

Innate Pharma reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

EPS
Quarterly Revenue
Annual Revenue
(as of Jun 30)
$24.9M

Analyze the earnings history of Innate Pharma using advanced sorting and filters.

Data brought to you by Benzinga APIs

Innate Pharma (IPHYF) Earnings Per Share

Quarterly Earnings Surprise Amount

no data available to display
Fiscal Quarter EndDate ReportedActual EPSEstimated EPSSurprise %

Innate Pharma (IPHYF) Revenue

Quarterly Revenue Surprise Amount

no data available to display
Fiscal Quarter EndDate ReportedActual RevenueEstimated RevenueSurprise %

FAQ

Q

When is Innate Pharma (OTCPK:IPHYF) reporting earnings?

A

There are no earnings for Innate Pharma

Q

What were the latest earnings per share (EPS) for Innate Pharma (OTCPK:IPHYF)?

A

There are no earnings for Innate Pharma

Q

What were Innate Pharma’s (OTCPK:IPHYF) revenues?

A

There are no earnings for Innate Pharma

Browse earnings estimates, EPS, and revenue on all stocks.